CDKN2A and mesothelioma: Although not investigated, this may correspond to differences in tumour growth seen in mesothelioma mouse models where co-alterations of BAP1, NF2 and CDKN2A/B led to a faster tumour growth compared to tumours with alterations in only one or two genes [17].